Skip to main content

valganciclovir

Generic: VALGANCICLOVIR HYDROCHLORIDE·Brand: VALCYTE, VALGANCICLOVIR HYDROCHLORIDE, Valcyte

valganciclovir: 3 clinical trials tracked.

valganciclovir evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about valganciclovir, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (3)

Initial Safety Lead-in Followed by a Phase II Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection (The Breast CMV Study)

NCT07383649Registry updated 2026-08-10·Phase 2
Recruiting

Primary endpoint: Objective Response Rate with anti-HMCV Therapy and SOC

Interventionalopen28 targetStarted 2026-07Completion 2030-051 site · United StatesThe Methodist Hospital Research Institute

Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

NCT06034925Registry updated 2025-10-07·Phase 4
Completed

Primary endpoint: Compare the proportion of patients that develop leukopenia in those randomized to maribavir versus those randomized to valganciclovir prophylaxis in adult kidney transplant recipients at high-risk of CMV infection.

InterventionalRandomizedopen70 enrolledStarted 2023-11Completion 2025-081 site · United StatesMedical University of South Carolina

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

NCT03511118Registry updated 2026-02-11·N/A
Recruiting

Primary endpoint: M/P ratio

Observational1,600 targetStarted 2018-10Completion 2027-0722 sites · Canada, United StatesDuke University